Yarrow Bioscience (YARW) EBITDA Margin (QoQ) (2017 - 2026)
Yarrow Bioscience (YARW) EBITDA Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - |
| 10 | Yarrow Bioscience | 31.15 Mn | 8.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71,400.00 |
| Jun 30, 2025 | -294,350.00 |
| Mar 31, 2025 | 1.08 Mn |
| Dec 31, 2024 | -456,653.00 |
| Sep 30, 2024 | -556,850.00 |
| Jun 30, 2024 | 212,949.00 |
| Mar 31, 2024 | 160,947.00 |
| Dec 31, 2023 | -352,105.00 |
| Sep 30, 2023 | 484,958.00 |
| Jun 30, 2023 | -444,300.00 |
| Mar 31, 2023 | 2.17 Mn |
| Dec 31, 2022 | -2.19 Mn |
| Sep 30, 2022 | 98,836.00 |
| Jun 30, 2022 | -169,440.00 |
| Mar 31, 2022 | -164,229.00 |
| Dec 31, 2021 | 485,520.00 |
| Sep 30, 2021 | -486,091.00 |
| Jun 30, 2021 | 100,760.00 |
| Mar 31, 2021 | -372,913.00 |
| Dec 31, 2020 | 20,556.00 |